Cegedim: Consolidated Accounts as at 30 June 2004.BOULOGNE Bou·logne also Bou·logne-sur-Mer A city of northern France on the English Channel north-northwest of Amiens. Of Celtic origin, it is the leading fishing port of France. Population: 44,800. , France -- Cegedim (Other OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). :CGMJF.PK) (BOURSE bourse (b  rs), term applied to a European stock exchange. The first international bourse was established in Antwerp in the 16th cent. :CGDM CGDM Consortium on Green Design and Manufacturing .PA):
CEGEDIM GROUP 30 June 30 June Variation 31 December
2004 2003 30 June 2003
EUR '000 EUR '000 % EUR '000
-------------------------- --------- --------- ----------- -----------
Turnover 212,087 191,243 10.9% 389,010
Production inventoried &
own work capitalized 195 -150 50
Purchases +/- inventory
change -13,664 -8,417 62% -18,707
-------------------------- --------- --------- ----------- -----------
Gross margin 198,618 182,676 9% 370,353
-------------------------- --------- --------- ----------- -----------
Other Purchases &
external charges -63,780 -60,054 6% -119,634
-------------------------- --------- --------- ----------- -----------
Value added 134,838 122,622 10.0% 250,719
-------------------------- --------- --------- ----------- -----------
Wages & salaries and
social security charges -92,808 -86,792 7% -170,953
Taxes (other than
corporation tax) -4,289 -4,054 6% -8,242
Subsidies 203 0 75
-------------------------- --------- --------- ----------- -----------
EBITDA (after local
taxes) 37,944 31,776 19.4% 71,599
-------------------------- --------- --------- ----------- -----------
Depreciation -13,527 -12,189 11% -26,044
Provisions -1,420 -1,149 24% -3,092
Depreciation, provisions
and charges written back 2,099 2,201 -5% 4,334
Other operating income &
charges -487 -152 -434
-------------------------- --------- --------- ----------- -----------
EBIT 24,609 20,487 20.1% 46,363
-------------------------- --------- --------- ----------- -----------
Financial income 1,520 769 98% 2,287
Financial charges -2,988 -2,802 7% -7,702
-------------------------- --------- --------- ----------- -----------
Net financial income -1,468 -2,033 -28% -5,415
-------------------------- --------- --------- ----------- -----------
Profit before taxation 23,142 18,454 25.4% 40,948
-------------------------- --------- --------- ----------- -----------
Net extraordinary income -1,382 -889 55% -603
Taxation -8,015 -6,280 28% -16,717
-------------------------- --------- --------- ----------- -----------
Net profit of
consolidated companies 13,745 11,285 21.8% 23,628
-------------------------- --------- --------- ----------- -----------
Goodwill amortization -3,039 -2,235 36% -4,684
Share of profits in
affiliate undertakings 21 -32 -17
Minority interests 86 -254 -407
-------------------------- --------- --------- ----------- -----------
Total consolidated net
profit
(group share) 10,812 8,764 21.4% 18,520
========================== ========= ========= =========== ===========
========================== ========= ========= =========== ===========
EBITA / Turnover 11.6% 10.7% 11.9%
========================== ========= ========= =========== ===========
Strong growth of operating profitability Consolidated turnover increases by 11% compared to the first half of 2003. EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) A metric used to show a company's profitability, but not its cash flow. EBITDA became popular in the 1980s to show the potential profitability of leveraged buyouts, but has become is up 19% and EBITA EBITA Earnings Before Interest Taxes Amortization grows by 20% (including favourable comparison basis in 2003, as the first half results were relatively lower than the second half results). The Scandinavian group Pharma Marketing, acquired in April 2004, accounts for almost EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 3 million in turnover and EUR 0.5 million in operating profit Operating profit (or loss) Revenue from a firm's regular activities less costs and expenses and before income deductions. operating profit See operating income. . Profitability (EBITA / turnover) stands at 11.6% as at 30 June June: see month. 2004, against 10.7% as at 30 June 2003. Distribution per sector Turnover EBITA EBITA/Turnover 30/06/2004 EUR '000 ------------------------------------ --------- -------- -------------- CRM and strategic data 96,648 15,561 16.1% ------------------------------------ --------- -------- -------------- Healthcare professionals 47,127 5,138 10.9% ------------------------------------ --------- -------- -------------- Electronic money, insurance and cash flows in the healthcare sector 34,705 4,025 11.6% ------------------------------------ --------- -------- -------------- Technologies and services 33,608 -115 -0.3% ------------------------------------ --------- -------- -------------- Total 212,088 24,609 11.6% ==================================== ========= ======== ============== Health and strategic data The core business activities dedicated to the pharmaceutical companies ("CRM (Customer Relationship Management) An integrated information system that is used to plan, schedule and control the presales and postsales activities in an organization. and strategic data") record an organic growth of more than 7% in turnover and 18% in EBITA. Services for "Healthcare professionals" (doctors and pharmacists This is a list of notable pharmacists.
On the contrary, profitability slightly shrinks with regard to "Electronic money, insurance and cash flows" activities in the healthcare sector. Combined factors can explain such trend: the ongoing integration of Proval, the current reorganization following the disposal of businesses which occurred during the second semester se·mes·ter n. One of two divisions of 15 to 18 weeks each of an academic year. [German, from Latin (cursus) s of 2003 and the beginning of 2004 and the launch of a new package in the field of electronic transmissions. However, the margin recovery is still expected for 2005. Technologies and services Turnover grows by 4% globally. An increase of the operating profit will occur over the second semester, thanks to new deals signed and the seasonal revival of sales in electronic documents management. Annual forecast The consolidated turnover should globally increase by roughly 9%. The operating profit should rise by 15% over the whole year 2004 compared to 2003, including significant charges dealing with the international expansion of the CAM's offer, which shall be launched shortly. Moreover, Cegedim enjoys positive developments, especially with regard to an enlarged co-operation with Sanofi Aventis Aventis Is a pharmaceutical and lab assay testing company. It was formed in 1999 when Rhône-Poulenc S.A. merged with Hoechst AG. The merged company was based in Strasbourg, France. Sanofi-Aventis was formed in 2004 when Sanofi-Synthélabo purchased Aventis. , the management of the public reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. system in the healthcare sector in Morocco Morocco, country, Africa Morocco (mərŏk`ō), officially Kingdom of Morocco, kingdom (2005 est. pop. 32,726,000), 171,834 sq mi (445,050 sq km), NW Africa. and the acquisition of promising businesses: Hospitalis (since March) dealing with the management of hospitals orders to the healthcare industry and Selectis (in October October: see month. ) dealing with the management of pension insurance. Cegedim also reinforces significantly its positions in the United-Kingdom, with the acquisition of the "pharmacists software" business of NDC NDC National Drug Code NDC NATO Defense College NDC National Documentation Centre (National Hellenic Research Foundation, Athens, Greece) NDC National Dairy Council NDC National Democratic Congress Health, and the acquisition of NDC Health's shares of InfoPharm, now wholly owned (see separate communique dated 26/10/04). Public company with share capital of 8,891,004.61 euros Registered office: 127 a 137 rue d'Aguesseau, 92100 Boulogne Trade and Commercial Register: Nanterre Nanterre (näNtâr`), city (1990 pop. 86,627), capital of Hauts-de-Seine dept., N central France, on the right bank of the Seine River. B 350 422 622 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion